We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Using Rapid Antigen Tests To Fight SARS-CoV-2
Industry Insight

Using Rapid Antigen Tests To Fight SARS-CoV-2

Technology Networks recently interviewed Anthony V. Lemmo, to learn how rapid antigen tests work, how they compare to PCR tests and how they can be used to help slow the spread of SARS-CoV-2.
COVID-19: Therapeutics, Preventives and Industry Perspectives
Industry Insight

COVID-19: Therapeutics, Preventives and Industry Perspectives

Technology Networks had the pleasure of speaking with Ki-Sung Kwon, head of the R&D unit at Celltrion to learn more about therapeutic versus preventive strategies against COVID-19 and the company's monoclonal antibody-based therapeutic – CT-P59 – that is currently being developed against COVID-19.
Tackling the Spread of SARS-CoV-2 Variants
Industry Insight

Tackling the Spread of SARS-CoV-2 Variants

Public health groups and leaders around the world are adopting different approaches for viral tracking and monitoring to halt the spread of novel SARS-CoV-2 variants.
A Skin Test To Measure T-Cell Immunity to SARS-CoV-2
Industry Insight

A Skin Test To Measure T-Cell Immunity to SARS-CoV-2

Technology Networks recently had the pleasure of speaking to Seth Lederman, president and chief executive officer of Tonix Pharmaceuticals, to learn more about the T-cell response to SARS-CoV-2, how it compares to the antibody response and the importance of measuring it during the pandemic.
The Development of Natural Killer Cells for Solid Tumor Treatment
Industry Insight

The Development of Natural Killer Cells for Solid Tumor Treatment

We interviewed Jan Davidson MD., PhD., the newly appointed chief medical officer at Wugen to learn more about the company's agreement with Washington University to further their Memory NK Cell program.
Supporting Scientists Responding to the COVID-19 Pandemic
Industry Insight

Supporting Scientists Responding to the COVID-19 Pandemic

The development and implementation of efficient tests is crucial in efforts to reduce the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
An Automated Age for Western Blotting
Industry Insight

An Automated Age for Western Blotting

Western blotting has been a core technique in molecular biology for many years, however, optimization and reproducibility can be problematic. We spoke to Dr Alexandre Lucas about the automation of western blotting and the difference this advance is making to research.
How Can Artificial Intelligence Stop the Spread of Antimicrobial Resistance?
Industry Insight

How Can Artificial Intelligence Stop the Spread of Antimicrobial Resistance?

As we begin to see the light at the end of the COVID-19 pandemic, the threat of antimicrobial resistance has not gone away and remains a priority. Precision medicine company OpGen use molecular diagnostics and informatics to identify AMR before it can spread. To find out more, Technology Networks caught up with OpGen's CEO Oliver Schacht.
Lab of the Future Post-COVID-19: Bringing User Experience to the Forefront
Industry Insight

Lab of the Future Post-COVID-19: Bringing User Experience to the Forefront

UX designers are keen to help researchers adapt lab technology to fit remote working practices and prevent instances where company technology is bypassed completely. Here are five trends we expect to see in user experience in the life sciences (UXLS) post-COVID-19.
Accelerating Scientific Study With Scalable Single-Cell Sequencing
Industry Insight

Accelerating Scientific Study With Scalable Single-Cell Sequencing

Technology Networks recently interviewed Alex Rosenberg, co-founder and CEO of Parse Biosciences to learn more about the company and its novel approach to single-cell sequencing.
Advertisement